Clinical Trials on Cup Size THP in United Kingdom

Total 30003 results

University of Nottingham

Unknown

Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis (STAR-MS)

Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis (AIMS)

Multiple Sclerosis

United Kingdom
University of Nottingham

Withdrawn

Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. (WIRMS-1)

Multiple Sclerosis

United Kingdom
Blue Earth Diagnostics
Syne Qua Non Limited; Innovate UK; IND 2 Results LLC

Completed

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer (FALCON)

Cancer of the Prostate

United Kingdom
The Royal Orthopaedic Hospital NHS Trust

Recruiting

Patient Specific Guides and Surgical Planning for Periacetabular Osteotomy; Post Marketing Evaluation Study (MyPAO)

Acetabular Dysplasia | Periacetabular Osteotomy | Pelvic Osteotomy

United Kingdom
Royal Marsden NHS Foundation Trust

Completed

Validation of a Nutrition Screening Tool

Sarcoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Adenocarcinoma of the Gastroesophageal Junction

United Kingdom
Imperial College London

Recruiting

Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target (TSPO)

Multiple Sclerosis

United Kingdom
Glasgow Caledonian University
NHS Lanarkshire; MS Society, UK

Completed

Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Terminated

Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis (CAM-THY)

Multiple Sclerosis

United Kingdom
North Bristol NHS Trust
Sir Halley Stewart Trust

Completed

Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis (SIAMMS-II)

Multiple Sclerosis

United Kingdom
University of the West of Scotland
National Heatlh Service Ayrshire and Arran

Unknown

Exercise Intensity and Immune Function in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Spinal Kinetics

Enrolling by invitation

M6-C Post Approval Study (PAS)

Long Term Follow-up

United States
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Recruiting

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Multiple Sclerosis

United Kingdom
Lancashire Teaching Hospitals NHS Foundation Trust

Completed

Virtual Reality in Motor Neurone Disease (VR in MND)

Motor Neuron Disease

United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)

Pulmonary Hypertension, Persistent, of the Newborn

United Kingdom
East Kent Hospitals University NHS Foundation Trust

Completed

Robotics for Mobility Rehabilitation in MS (RAPPERIII)

Multiple Sclerosis | MS

United Kingdom
University College, London
Cambridge University Hospitals NHS Foundation Trust

Completed

A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas (CONCYST)

Pancreatic Cyst | Cystadenoma, Mucinous | Intraductal Papillary Mucinous Neoplasm | Serous Cystadenoma

United Kingdom
Trio Medicines Ltd.
Biogen

Completed

Avonex®: Safety, Blood Levels and Effects (C-851)

Multiple Sclerosis (MS)

United Kingdom
Andrew D Duckworth

Terminated

A Trial of Non-operative Versus Operative Management of Olecranon Fractures in the Elderly

Olecranon Fractures in the Elderly

United Kingdom
NHS Greater Glasgow and Clyde
Biogen

Enrolling by invitation

Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE (MODERATE)

Relapsing Remitting Multiple Sclerosis

United Kingdom
King's College Hospital NHS Trust
Manchester Metropolitan University

Completed

Surface EMG and Ultrasound in MND

Motor Neuron Disease

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

Telehealth in Motor Neurone Disease (TiM)

Motor Neuron Disease

United Kingdom
Stanford University
University of North Carolina, Chapel Hill; Oregon Research Institute

Not yet recruiting

Effects of Processed Foods on Brain Reward Circuitry and Food Cue Learning

Ultra-processed Foods (UP)

United States
Sorrento Therapeutics, Inc.

Enrolling by invitation

Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy

Long-term Follow-up

United States
University of Edinburgh

Completed

Self Help for Fatigue in Multiple Sclerosis

Multiple Sclerosis | Fatigue

United Kingdom
Knopp Biosciences
Biogen

Completed

Dexpramipexole Japanese PK Study

Amyotrophic Lateral Sclerosis

United Kingdom
North Bristol NHS Trust
University of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaborators

Unknown

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) (ACTiMuS)

Progressive Multiple Sclerosis

United Kingdom
University of Glasgow
NHS Ayrshire and Arran; AKM

Completed

Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.

Progressive Multiple Sclerosis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Comparative Oral Bioavailability Study of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
Nutricia Research

Unknown

Neocate In Infants and Children With Complex Conditions (NICC)

Complex Conditions, Including Impairment of the GI Tract

United Kingdom, United States, Germany
Queen Mary University of London

Terminated

Neurofilaments for NEDA Assessing in MS

Multiple Sclerosis

United Kingdom
AbbVie

Terminated

[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Glasgow Caledonian University

Unknown

Exercise to Manage Fatigue in Progressive Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of the Long-term Safety of Sativex Use

Pain | Multiple Sclerosis | Spasticity

United Kingdom
Queen Mary University of London
Merck Sharp & Dohme LLC

Completed

Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE)

Relapsing Remitting Multiple Sclerosis

United Kingdom
Medacta International SA

Active, not recruiting

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

Arthritis | Osteoarthritis | Avascular Necrosis | Congenital Hip Dysplasia | Fracture of the Femoral Neck or Head

Switzerland, United Kingdom
Jazz Pharmaceuticals

Completed

A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

Multiple Sclerosis | Neuropathic Pain

United Kingdom
Queen Margaret University
NHS Lothian

Completed

Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop

Multiple Sclerosis

United Kingdom
NHS Greater Glasgow and Clyde
University of Glasgow

Unknown

Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study (ICA-GBS)

Gullian Barre Syndrome

United Kingdom
University of Nottingham

Unknown

Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis

Carer Stress Syndrome

United Kingdom
University of Edinburgh
Medical Research Council; NHS Lothian

Completed

Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome (AGS-RTI)

Aicardi-Goutières Syndrome

United Kingdom
Genentech, Inc.
Quotient Clinical

Completed

Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants

Amyotrophic Lateral Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

Pain | Multiple Sclerosis

United Kingdom
Boston Scientific Corporation

Terminated

Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)

Chronic Neuropathic Pain in the Low Back and Legs

United Kingdom
University of Glasgow
NHS Greater Glasgow and Clyde; Tenovus Scotland

Recruiting

Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy

Breast Cancer | HER2-positive Breast Cancer | Cardiotoxicity

United Kingdom
University of Edinburgh
NHS Lothian

Completed

The Impact of Positive Mental Training in Multiple Sclerosis (PosMTMS)

Multiple Sclerosis | Psychological Distress

United Kingdom
Cartiheal (2009) Ltd

Active, not recruiting

Agili-C™ Implant Performance Evaluation

Cartilage or Osteochondral Defects in the Knee | Up to Moderate Osteoarthritis

United States, Israel, Belgium, Italy, Serbia, Hungary, Poland, Romania
University of Glasgow
NHS Ayrshire and Arran; AKM

Completed

The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis.

Multiple Sclerosis, Progressive

United Kingdom
Cancer Research UK
Hummingbird Bioscience

Recruiting

HMBD-001 in Advanced HER3 Positive Solid Tumours

Melanoma | Cervical Cancer | Gastric Cancer | Pancreatic Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Bladder Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Non-small Cell Lung Cancer (NSCLC) | Oesophageal Cancer | RAS Wild Type Colorectal Cancer | Squamous Cell Cancer of the Head and Neck

United Kingdom

Clinical Trials on Cup Size THP in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations